SCHEMBL19485403

SCHEMBL19485403

CC(=O)OCC(O)COP(=O)(O)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 7/20 0.42
LPAR5 Q9H1C0 4/20 0.42
LPAR4 Q99677 3/20 0.42
LPAR2 Q9HBW0 3/20 0.42
LPAR3 Q9UBY5 3/20 0.42
ENPP2 Q13822 3/20 0.42
LPAR6 P43657 2/20 0.42
LAP3 P28838 1/20 0.41
TDP1 Q9NUW8 1/20 0.38
CES2 O00748 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
USP2 O75604 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2935219 0.83 LPAR1 (0.57) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL4572575 0.83 LPAR1 (0.57) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL304203 0.78 TDP1 (0.54) TDP1USP2ALDH1A1CYP3A4MAPT
SCHEMBL15385433 0.77 P2RY10 (0.46) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL4572553 0.77 P2RY10 (0.43) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL14417988 0.77 SMN1; SMN2 (0.45) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL14823175 0.75 P2RY10 (0.47) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL18294593 0.74 LPAR5 (0.47) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL13854735 0.73 USP2 (0.41) LPAR1LPAR5LPAR4LPAR2LPAR3
SCHEMBL20682445 0.73 P2RY10 (0.43) LPAR1LPAR5LPAR4LPAR2LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170298083-A1 NEW IMMUNOSTIMULATORY COMPOUNDS Bernhard-Nocht-Institut für Tropenmedizin (DE) 2017-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298083-A1 NEW IMMUNOSTIMULATORY COMPOUNDS NFATC1, TLR5, IL5 LPAR1 466/4885LPAR5 251/4885LPAR4 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.